DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Zelber-Sagi S, Kessler A, Brazowsky E. et al.
A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.
Clin Gastroenterol Hepatol 2006;
4 (05) 639-644
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.